Top 40 Insitro investors
The most complete profiles first. Showing 40 of 52.
Andy KimVerified
Venture Capital, Investor · United States
SeedSeries AHealth CareCustomer ServiceCybersecurityDatabasesPortfolio: Kasisto, Flatfile, CoverWallet, NewtonX and 50 more
Verified email available
Brett ZbarVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedInvestment ManagementPortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 68 more
Verified email available
Carol SuhVerified
Venture Capital, Investor · United States
Series BHealth CareLife ScienceBiotechnologyHealth DiagnosticsPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Christoph LengauerVerified
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Verified email available
Craig MuirVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Verified email available
David CruikshankVerified
Venture Capital, Investor · United States
Series BHealth CareLife ScienceBiotechnologyHardwarePortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Dennis RyanVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedLife SciencePortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Verified email available
Dorothy MargolskeeVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedLife SciencePortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Verified email available
Edward SchmidtVerified
Venture Capital, Micro VC, Investor · United States
SeedSeries AHealth CareData ScienceCustomer ServiceCybersecurityPortfolio: Kasisto, Flatfile, CoverWallet, NewtonX and 50 more
Verified email available
Eli CasdinVerified
Venture Capital, Founder, Micro VC · United States
SeedHealth CareGeneticsWellnessWomen FoundedPortfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 76 more
Verified email available
Frances SchwiepVerified
Venture Capital, Investor · United States
Series BSeries AHealth CareCustomer ServiceCybersecurityDatabasesPortfolio: Kasisto, Flatfile, CoverWallet, NewtonX and 51 more
Verified email available
Krishna YeshwantVerified
Venture Capital, Corporate Venture Capital, Investor · United States
Series BHealth CareTelecommunicationsHospitalsE-commercePortfolio: Pixie, Dialpad, Science 37, Synack and 90 more
Verified email available
Kyra DurkoVerified
Venture Capital, Investor · United States
SeedSeries AHealth CareCustomer ServiceCybersecurityDatabasesPortfolio: Kasisto, Flatfile, CoverWallet, NewtonX and 50 more
Verified email available
Matt GreenwoodVerified
Venture Capital, Micro VC, Investor · United States
SeedSeries AHealth CareData ScienceCustomer ServiceCybersecurityPortfolio: Kasisto, Flatfile, CoverWallet, NewtonX and 50 more
Verified email available
Matt TaylorVerified
Venture Capital, Advisor, Private Equity Firm · United Kingdom
SeedHealth CareHospitalsWomen FoundedLife SciencePortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Verified email available
Rhonda KaufmanVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedLife SciencePortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Verified email available
Robert TepperVerified
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Verified email available
Sean KendallVerified
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareEnterprise SoftwareEnergyChemicalPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Brian BulgerVerified
Investment Bank · United States
Health CareTelecommunicationsE-commerceCybersecurityPortfolio: Acorns, Goldfinch Biopharma, Domo, Icelandic Glacial and 80 more
Verified email available
Fady YacoubVerified
Entrepreneurship Program · United States
Health CareE-commerceAccountingCustomer ServicePortfolio: UiPath, Dapper Labs, Arcus, Myome and 27 more
Verified email available
Jason MehringVerified
Investment Bank, Finance Operator · United States
Health CareTelecommunicationsE-commerceCybersecurityPortfolio: Acorns, Goldfinch Biopharma, Domo, Icelandic Glacial and 80 more
Verified email available
Karim FarisVerified
Venture Capital, Corporate Venture Capital · United States
Health CareTelecommunicationsE-commerceConsumer GoodsPortfolio: Pixie, Dialpad, Science 37, Synack and 87 more
Verified email available
Mark McDonnellVerified
Venture Capital · United States
Health CareLife ScienceBiotechnologyHealth DiagnosticsPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Michael LeitnerVerified
Investment Bank · United States
Health CareTelecommunicationsE-commerceCybersecurityPortfolio: Acorns, Goldfinch Biopharma, Domo, Icelandic Glacial and 80 more
Verified email available
Noreen RizviVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Verified email available
Onsi SawirisVerified
Entrepreneurship Program · United States
Health CareE-commerceAccountingCustomer ServicePortfolio: UiPath, Dapper Labs, Arcus, Myome and 27 more
Verified email available
Tom BrennanVerified
Venture Capital, Private Equity Firm · United States
Health CareEnterprise SoftwareLife ScienceInformation Technology (IT)Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Victor WangVerified
Venture Capital, Private Equity Firm, Angel/Individual · United States
SeedPre-SeedE-commercePaymentsEnterprise SoftwareCryptocurrencyPortfolio: Explorex, Ovid Research, Alethea AI, Metagenomi and 4 more
Verified email available
Abbie Celniker
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 54 more
Contact details available
Cary Pfeffer
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
Corey Ritter
Venture Capital, Investor · United States
Series BHealth CareLife ScienceRoboticsManufacturingPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Contact details available
George Xu
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
Luke Bagaason, CFA
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedInvestment ManagementPortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Contact details available
Mark Levin
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceEducationPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
Neil Exter
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
Nilay Thakar
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Contact details available
Paul Quigley
Venture Capital, Entrepreneurship Program, Investor · United States
SeedPre-SeedHealth CareE-commerceAccountingCustomer ServicePortfolio: UiPath, Dapper Labs, Arcus, Myome and 27 more
Contact details available
Richard Lau, CFA
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedInvestment ManagementPortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Contact details available
Steve Gillis
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 68 more
Contact details available
Adeline Oursler
Micro VC · United States
Health CareGeneticsWellnessWomen FoundedPortfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more
Contact details available
See all 52 Insitro investors
Search, filter and unlock verified emails and LinkedIn profiles. Free to browse.
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Insitro investors are on Angel Roster?
Angel Roster lists 52 Insitro investors. 28 of them (54%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (39), Private Equity Firms (18) and Investment Banks (9). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Insitro investors invest in?
Among those that list a stage, the most common are Seed (22), Series B (9) and Series A (5).
Where are Insitro investors based?
Most are based in the United States (50) and the United Kingdom (2).
Which companies have Insitro investors backed?
The most-backed portfolio companies among them are Decibel Therapeutics (33), Maze Therapeutics (31), Goldfinch Biopharma (24), Relay Therapeutics (23) and Fulcrum Therapeutics (22).
How do I contact Insitro investors?
Create a free Angel Roster account to search and filter all 52, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.